Why Successful Companies Are ‘Tough On Themselves’ When It Comes To HTA

Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.

Companies need to pressure test their clinical development strategies in light of the EU HTA Regulation (Shutterstock)

More from Interviews

More from R&D